Aram Huvis Expands Global Reach with AI-Powered Customized Cosmetics Technology

Aram Huvis, South Korea's first customized cosmetics company specializing in precise skin and scalp diagnosis technology combined with AI big data analysis, is transforming the beauty industry through its innovative approach to personalized care. The company's core strengths lie in its advanced AI algorithms, clinical verification by dermatology experts at Seoul National University Bundang Hospital, and extensive database of over 100,000 scalp-related records accumulated over 22 years of operation.

The company's flagship product, the AI Scalp Grader (AISG), recognized as an Innovation Awards Honoree at CES 2023, provides AI-powered real-time analysis that enables the formulation of customized shampoos and serums tailored to individual needs. This technology has attracted significant global attention, with major cosmetics brands including LVMH, L'Oréal, Estée Lauder, P&G, and Aveda leveraging Aram Huvis' diagnostic solutions to develop their own customized products. The company's technology has also been adopted by leading hair salon chains such as Schwarzkopf, demonstrating its broad applicability across different segments of the beauty industry.

Clinical validation conducted in collaboration with dermatologists from Seoul National University Bundang Hospital has demonstrated the efficacy of Aram Huvis' products. In a four-week trial involving 100 participants, the customized skincare solution reduced risk factors by 51% and achieved a 93% satisfaction rate. The company holds the unique distinction of being the only entity authorized to manufacture and sell personalized cosmetics in South Korea, following regulatory exemptions granted by the Ministry of Trade, Industry, and Energy.

Aram Huvis' global expansion strategy has yielded substantial results, with products exported to over 70 countries through 30 official distributors worldwide. Recent business developments include NDA negotiations with an Israeli cosmetics firm at CES 2025 targeting sales exceeding KRW 300 million, and a finalized distribution contract in India aiming for annual revenue of KRW 600 million. The company is actively negotiating new dealership agreements in Portugal, Panama, Switzerland, and Qatar, indicating robust international growth momentum.

The company's commitment to research and development is evidenced by its allocation of 18.92% of revenue to R&D, significantly surpassing South Korea's corporate average of 2.89%. This substantial investment enables the development of more sophisticated diagnostic solutions and positions Aram Huvis as a pioneer in the personalized cosmetics market. The company's focus on preservative-free cosmetics made from natural ingredients specifically caters to consumers with sensitive skin, reinforcing its commitment to high-quality skincare solutions.

In 2025, Aram Huvis plans to launch several new initiatives, including the Medi Custom brand specializing in hand creams for nurses, expansion of sales channels for its atopic skincare brand Atorien, and introduction of the personalized scalp care brand Lilai. These developments aim to accelerate the company's B2C business and achieve aggressive sales growth, marking a strategic shift from its traditional B2B-centric model that involved supplying diagnostic devices and tailored cosmetics to hospitals and clinics in Korea.

Operating from South Korea's premier technology hub in Pangyo, Aram Huvis leverages the region's vibrant startup ecosystem and government support to refine its business strategies. The company's presence in Pangyo Techno Valley, a global integrated R&D hub focused on IT, BT, CT, and NT, provides access to cutting-edge research facilities and collaborative opportunities that enhance its technological capabilities. As Gyeonggi-do's representative innovation cluster, Pangyo Techno Valley supports companies like Aram Huvis through monthly events and overseas promotion programs that facilitate foreign investment and global market access.

The implications of Aram Huvis' technological advancements and global expansion are significant for the beauty and healthcare industries. The company's AI-driven approach to personalized cosmetics represents a paradigm shift from mass production to individualized care, potentially setting new standards for product efficacy and customer satisfaction. With proven clinical results and partnerships with industry leaders, Aram Huvis is positioned to influence global beauty trends while driving innovation in personalized healthcare solutions.